Solventum Corp. Files 8-K Amid Corporate Changes

Ticker: SOLV · Form: 8-K · Filed: 2024-04-04T00:00:00.000Z

Sentiment: neutral

Topics: corporate-event, spin-off, governance, legal-agreement

Related Tickers: MMM

TL;DR

Solventum Corp (formerly 3M Health Care) filed an 8-K on 3/31, detailing material agreements, exec changes, and bylaws updates. Big corporate shift incoming.

AI Summary

Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on April 4, 2024, reporting events as of March 31, 2024. The filing indicates a material definitive agreement, modifications to security holder rights, changes in officers and directors, amendments to governing documents, and other events. This filing marks a significant corporate transition for Solventum.

Why It Matters

This 8-K filing signals significant corporate restructuring and potential changes in governance and agreements for Solventum Corporation, which was formerly part of 3M.

Risk Assessment

Risk Level: medium — The filing details multiple material events including definitive agreements and changes in officers/directors, which can introduce uncertainty and risk.

Key Players & Entities

FAQ

What specific material definitive agreement was entered into by Solventum Corporation?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.

What were the key changes regarding directors or officers reported in the 8-K?

The 8-K reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements for certain officers.

When did Solventum Corporation officially change its name from 3M Health Care Co.?

The date of the name change from 3M Health Care Co. to Solventum Corporation was February 3, 2023.

What is Solventum Corporation's Standard Industrial Classification (SIC) code?

Solventum Corporation's SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the fiscal year end for Solventum Corporation?

Solventum Corporation's fiscal year ends on December 31.

From the Filing

0001628280-24-014887.txt : 20240404 0001628280-24-014887.hdr.sgml : 20240404 20240404164152 ACCESSION NUMBER: 0001628280-24-014887 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240331 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 24823643 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solventum-closing8xk4324.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2024 Solventum Corporation (Exact name of registrant as specified in its charter) Delaware 001-41968 92-2008841 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East Maplewood, MN 55144 (Address of Principal Executive Offices, including Zip code) (651) 733-1110 (Registrant’s telephone number, including area code) (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share SOLV New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01.    Entry into a Material Definitive Agreement. Separation-Related Agreements On March 31, 2024, Solventum Corporation (“Solventum”)

View on Read The Filing